SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-017997
Filing Date
2020-09-18
Accepted
2020-09-18 08:05:11
Documents
5
Period of Report
2020-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 39528
2 ex10-1.htm EX-10.1 88470
3 ex10-2.htm EX-10.2 86401
4 ex99-1.htm EX-99.1 8282
5 ex99-1_001.jpg GRAPHIC 4348
  Complete submission text file 0001493152-20-017997.txt   230153
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 201182778
SIC: 2834 Pharmaceutical Preparations